Company Filing History:
1 out of 1 
1 out of 1,745 
1 out of 23 Years Active: 2015-2023
Title: The Innovative Contributions of David Deperthes
Introduction
David Deperthes is a notable inventor based in Etoy, Switzerland, recognized for his significant contributions to the field of medical science through his innovative inventions. With a strong background in therapeutic compounds, he has developed methods aimed at treating skin diseases and designing unique inhibitor proteins that play a crucial role in protease interactions.
Latest Patents
David Deperthes holds two patents that showcase his inventive prowess. The first patent focuses on the "Use of Serine Protease Inhibitors in the Treatment of Skin Diseases." This invention is centered around therapeutic compounds that inhibit serine proteases and outlines pharmaceutical compositions to treat or diagnose skin diseases. The key method involves administering a therapeutically effective amount of a serine protease inhibitor to individuals in need.
His second patent, titled "Inhibitor Proteins of a Protease and Use Thereof," relates to a chimeric inhibitor protein comprising an inhibiting polypeptide sequence paired with a polypeptide sequence specific to a protease's substrate-enzyme interaction site. This patent aims to provide a purified DNA sequence encoding the chimeric inhibitor protein and includes details on the production of the protein using transformed host cells.
Career Highlights
Throughout his career, David Deperthes has made significant strides in the medical field, contributing valuable inventions that have the potential to improve treatment outcomes for various skin diseases. He has worked with esteemed companies such as Dermadis SA and the National Institute for Health and Medical Research (Institut National de la Santé Et de La Recherche Médicale), where he applied his expertise in therapeutics and innovation.
Collaborations
In his journey as an inventor, David has collaborated with talented individuals such as Christoph Kundig and Alain Hovnanian. These partnerships have enhanced his research endeavors and contributed to the development of groundbreaking medical therapies.
Conclusion
David Deperthes continues to be a transformative figure in the realm of medical innovations, specifically concerning skin disease treatments and protease inhibitors. His patents reflect a dedication to advancing therapeutic strategies and improving the quality of life for individuals affected by these conditions. The ongoing impact of his work will undoubtedly be felt in the medical community for years to come.